Suppr超能文献

用于更复杂剂量探索研究的扩展基于模型的设计。

Extended model-based designs for more complex dose-finding studies.

机构信息

Inserm, Université Paris VI, Place Jussieu, 75005 Paris, France.

出版信息

Stat Med. 2011 Jul 30;30(17):2062-9. doi: 10.1002/sim.4024. Epub 2011 Feb 24.

Abstract

We discuss extensions of model-based designs, such as the continual reassessment method, for use in dose-finding studies. Rather than work with a single model to carry out the design and analysis of a dose-finding study we indicate how the use of several models can greatly increase flexibility. We can appeal to established results on Bayesian model choice and this device makes the inferential problem essentially straightforward. The greater flexibility enables us to take on board many different kinds of added complexity. Examples include extended models to deal with subject heterogeneity, extended models to take account of different treatment schedules and extended models to tackle the problem of partial ordering.

摘要

我们讨论了基于模型的设计的扩展,如连续再评估方法,用于剂量发现研究。我们不是使用单一模型来进行剂量发现研究的设计和分析,而是指出使用多个模型可以大大增加灵活性。我们可以诉诸于贝叶斯模型选择的既定结果,这种方法使推理问题变得非常简单。更大的灵活性使我们能够处理许多不同类型的附加复杂性。例如,扩展模型以处理个体间的异质性,扩展模型以考虑不同的治疗方案,以及扩展模型以解决部分排序问题。

相似文献

9
Choice of designs and doses for early phase trials.早期临床试验的设计与剂量选择。
Fundam Clin Pharmacol. 2004 Jun;18(3):373-8. doi: 10.1111/j.1472-8206.2004.00226.x.
10
A comparison of two phase I trial designs.两种I期试验设计的比较。
Stat Med. 1994 Sep 30;13(18):1799-806. doi: 10.1002/sim.4780131802.

引用本文的文献

3
The Impact of Early-Phase Trial Design in the Drug Development Process.药物研发过程中早期试验设计的影响。
Clin Cancer Res. 2019 Jan 15;25(2):819-827. doi: 10.1158/1078-0432.CCR-18-0203. Epub 2018 Oct 16.
4
Shift models for dose-finding in partially ordered groups.部分有序组中剂量探索的转换模型。
Clin Trials. 2019 Feb;16(1):32-40. doi: 10.1177/1740774518801599. Epub 2018 Oct 11.
5
Embracing model-based designs for dose-finding trials.采用基于模型的设计进行剂量探索试验。
Br J Cancer. 2017 Jul 25;117(3):332-339. doi: 10.1038/bjc.2017.186. Epub 2017 Jun 29.
6
Implementation of adaptive methods in early-phase clinical trials.早期临床试验中自适应方法的实施
Stat Med. 2017 Jan 30;36(2):215-224. doi: 10.1002/sim.6910. Epub 2016 Feb 29.
7
The changing landscape of phase I trials in oncology.肿瘤学中 I 期临床试验的变化格局。
Nat Rev Clin Oncol. 2016 Feb;13(2):106-17. doi: 10.1038/nrclinonc.2015.194. Epub 2015 Nov 10.

本文引用的文献

1
Retrospective robustness of the continual reassessment method.连续重新评估法的回顾性稳健性。
J Biopharm Stat. 2010 Sep;20(5):1013-25. doi: 10.1080/10543400903315732.
2
Model calibration in the continual reassessment method.序贯评估法中的模型校准
Clin Trials. 2009 Jun;6(3):227-38. doi: 10.1177/1740774509105076.
3
Designs for single- or multiple-agent phase I trials.单药或多药I期试验的设计。
Biometrics. 2004 Sep;60(3):661-9. doi: 10.1111/j.0006-341X.2004.00215.x.
4
Continual reassessment method for ordered groups.有序组的连续重新评估方法。
Biometrics. 2003 Jun;59(2):430-40. doi: 10.1111/1541-0420.00050.
7
Two-sample continual reassessment method.
J Biopharm Stat. 1999 Mar;9(1):17-44. doi: 10.1081/BIP-100100998.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验